SIGNAL GRIDv0.1

Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy

2 sources2 storiesFirst seen 5/4/2026Score40Mixed Progress
CoverageRecencyEngagementVelocityBignessConfidenceClipability
Bigness
40
Coverage
25
Recency
86
Engagement
14
Velocity
60
Confidence
62
Clipability
70
Polarization
0
Claims
3
Contradictions
0
Breakthrough
50

Sentiment Mix

Positive50%
Neutral50%
Negative0%

Geography

Asia

Expert Signals

Politics - Google News US Headlines

source1 mention

Fox News - Latest Headlines

source1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy - Fox News.

Supported by 1 story

Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy Fox NewsBreakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years SciTechDailyPre-Surgery Immunotherapy Shows Promising Results in Bowel Cancer The Indian PractitionerImmunotherapy Trial Shows 100 Percent Success Rate for Bowel Cancer Patients HarianBasis.co

Supported by 1 story

Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy.

Supported by 1 story

Related Events

Timeline (2 stories)

Receipts (2)

Bias Snapshot

Very Right
Left 0%Center 0%Right 100%
Blogfoxnews.com5/4/2026
Blognews.google.com5/4/2026